Physicians' Academy for Cardiovascular Education

What is the science driving CVD and T2DM?

Expert Meeting on CVD & T2DM

10' education - Mar. 22, 2018 - Wouter Jukema, Stephan Jacob, Ulf Landmesser - Online CME

Video navigation menu

  • Is diabetes truly a state of enhanced CV risk? 0:43
  • What is the impact of glucose-lowering in current diabetes management? 2:45
  • Side-effects of treatment may have offset the benefits of better glycemic control in the past 3:43
  • Which mechanisms, beyond glucose lowering, may contribute to the achieved CV risk reduction 6:10
  • Preventing weight gain and reducing obesity should be part of T2DM management 8:02
  • Concluding remarks 9:03

Educational information

This video was recorded during a two-day expert meeting among cardiologists and endocrinologists/internists, focussing on the topic of 'Exploring the role of GLP-1 RA in the management of CVD & T2DM'. This video reflects the discussion in the first of five sessions.



This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenters and do not necessarily reflect the views of PACE-cme.


Funding for the Expert Meeting was provided by an unrestricted educational grant from Novo Nordisk. The sponsor did not attend and influence the meeting or the video recording.

Also see: What are the key mechanisms of CV benefit of novel diabetes drugs? Also see: Clinical trials in diabetes and CVD: What did we learn?


This is available as accredited online CME for members. Click the button below to enroll:


Share this page with your colleagues and friends: